ZNF526 include a variety of compounds that enhance the phosphorylation state of the protein, thereby augmenting its functional activity. Forskolin is one such activator that directly increases intracellular cyclic adenosine monophosphate (cAMP) levels. This elevation in cAMP activates protein kinase A (PKA), which can then phosphorylate ZNF526, enhancing its activity. Similarly, Isoproterenol acts as a beta-adrenergic agonist to raise cAMP production, again engaging PKA to potentially phosphorylate and activate ZNF526. Another compound, IBMX, functions as a non-specific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP, resulting in PKA activation and subsequent phosphorylation of ZNF526.
PMA acts as an activator of protein kinase C (PKC), which has the capacity to phosphorylate serine and threonine residues on ZNF526, leading to its activation. Ionomycin, by elevating intracellular calcium levels, can activate calcium-dependent kinases, which may then target ZNF526 for activation. Thapsigargin, which inhibits the Ca2+ ATPase of the sarcoplasmic and endoplasmic reticulum, causes an increase in cytosolic calcium levels that could activate kinases capable of phosphorylating ZNF526. Okadaic Acid, known for its inhibition of serine/threonine phosphatases, results in an accumulation of phosphorylated proteins, which could include ZNF526, leading to its activation. Anisomycin activates stress-activated protein kinases, which are capable of phosphorylating ZNF526, while Calyculin A, by inhibiting phosphatases PP1 and PP2A, enhances the phosphorylation and activation potential of ZNF526. Dibutyryl-cAMP, a cell-permeable cAMP analogue, activates PKA and could thereby drive the phosphorylation and activation of ZNF526. Similarly, Phorbol 12-myristate 13-acetate is a direct activator of PKC which could also phosphorylate and activate ZNF526. Lastly, A23187, a calcium ionophore, increases calcium influx, thereby activating calcium-dependent kinases that can target ZNF526 for activation. Each of these chemicals acts through a specific pathway that ultimately leads to the enhanced phosphorylation and activation of ZNF526.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Acts as a beta-adrenergic agonist that increases cAMP production, thereby activating PKA which could phosphorylate and activate ZNF526. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Non-specific inhibitor of phosphodiesterases, increasing cAMP levels and subsequently activating PKA, which may lead to the activation of ZNF526. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which can phosphorylate serine and threonine residues on ZNF526, leading to its activation. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Increases intracellular calcium levels, potentially activating calcium-dependent protein kinases that could phosphorylate and activate ZNF526. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA) leading to a rise in cytosolic calcium levels, which may activate kinases that phosphorylate ZNF526. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits serine/threonine phosphatases, leading to increased phosphorylation levels and potential activation of ZNF526 by kinases. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates stress-activated protein kinases (SAPKs/JNKs), which could phosphorylate and activate ZNF526. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Inhibitor of serine/threonine phosphatases PP1 and PP2A, leading to increased phosphorylation and possible activation of ZNF526. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Cell-permeable cAMP analog that activates PKA, potentially leading to the phosphorylation and activation of ZNF526. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Ionophore that increases intracellular calcium, activating calcium-dependent kinases which may phosphorylate and activate ZNF526. | ||||||